SMCX Sank Year While AI Stocks Rally: A 2026 Market Tale
A 2x daily leveraged ETF tied to SMCI plunged as its underlying stock posted a modest gain. Experts say daily resets ...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesA 2x daily leveraged ETF tied to SMCI plunged as its underlying stock posted a modest gain. Experts say daily resets ...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
Global markets edge higher as AI spending sustains profits and optimism into the summer. Analysts say tech leadership...
The United States and its allies launched targeted strikes against facilities tied to Iran's leadership, triggering r...
Tech stocks swung wildly midday as traders dumped riskier names, then rotated into consumer staples and paints. By da...
Bitcoin is showing resilience as oil prices retreat, pointing to a possible shift in risk sentiment. This morning min...
Tech-led losses push the Nasdaq lower as investors weigh rates and policy risks. Markets remain volatile as traders m...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
BWET has surged on a geopolitically driven spike in tanker rates. The rally hinges on one event, and a calm could tri...
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Over the last decade, the iShares S&P 100 ETF led large-cap funds with outsized gains, but 2026’s early volatility hi...